Renin-angiotensin system blockade and kidney transplantation: A longitudinal cohort study

Nephrology Dialysis Transplantation

Volumn 27, Issue 1, 2012, Pages 417-422

  Hernández, Domingo ^a   Muriel, Alfonso ^b,c   Abraira, Víctor ^b,c   Pérez, Germán ^d   Porrini, Esteban ^d   Marrero, Domingo ^d   Zamora, Javier ^b,c   González Posada, José Manuel ^d   Delgado, Patricia ^d   Rufino, Margarita ^d   Torres, Armando ^d  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^d HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

angiotensin II receptor blockers; angiotensin converting enzyme inhibitor; kidney transplantation; marginal structural models; survival

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; RISK REDUCTION; SURVIVAL RATE; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; SURVIVAL RATE;

EID: 84856482663     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr276     Document Type: Article

References (28)

1. Pascual M, Theruvath T, Kawai T et al. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002; 346: 580-590 (Pubitemid 34438820)
2. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 (Suppl 3): S112-S119 (Pubitemid 28527268)
3. Meier-Kriesche HU, Schold JD, Srinivas TR et al. Lack of improvement in allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378-383 (Pubitemid 38282293)
4. Cruzado JM, Rico J, Grinyó JM. The renin angiotensin system blockade in kidney transplantation: pros and cons. Transpl Int 2008; 21: 304-313 (Pubitemid 351348021)
5. Artz MA, Hilbrands LB, Borm G et al. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant 2004; 19: 2852-2857 (Pubitemid 39480983)
6. Montanaro D, Gropuzzo M, Tulissi P et al. Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients. Transplant Proc 2005; 37: 991-993 (Pubitemid 40590769)
7. Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889-899
8. Opelz G, Zeier M, Laux G et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol 2006; 17: 3257-3262 (Pubitemid 44707788)
9. Hillebrand U, Suwelack BM, Loley K et al. Blood pressure, antihy-pertensive treatment, and graft survival in kidney transplant patients. Transpl Int 2009; 22: 1073-1080
10. Hernández AA, Moreso F, Bayés B et al. Angiotensin- converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain. NDT Plus 2010; 3 (Suppl 2): ii21-ii25
11. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11: 550-560 (Pubitemid 30660034)
12. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11: 561-570 (Pubitemid 30660035)
13. Solez K, Axelsen RA, Benediktsson H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-422 (Pubitemid 23228698)
14. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723 (Pubitemid 29082898)
15. Krumholz HM, Larson M, Levy D. Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879-884
16. Davidson J, Wilkinson A, Dantal J et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Transplantation 2003; 75 (10 Suppl): SS3-SS24
17. Kasiske BL, Guijarro C, Massy ZA et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158-165 (Pubitemid 26067103)
18. Wang AY, Wang M, Woo J et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003; 14: 159-168 (Pubitemid 36032720)
19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55
20. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281 (Pubitemid 28466823)
21. Fewell Z, Hernán MA, Wolfe F et al. Controlling for time-dependent confounding using marginal structural models. Stata J 2004; 4: 402-420
22. Cole SR, Hernán MA, Robins JM et al. Effect of highly active anti-retroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol 2003; 158: 687-694 (Pubitemid 37175517)
23. Sterne JA, Hernán MA, Ledergerber B et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet 2005; 366: 378-384 (Pubitemid 41073955)
24. Hiremath S, Fergusson D, Doucette S et al. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7: 2350-2360 (Pubitemid 47347851)
25. Heinze G, Oberbauer R. Does size matter? (letter). Nephrol Dial Transplant 2007; 22: 2725-2726
26. Gaston RS, Kasiske BL, Fieberg AM et al. Use of cardioprotective medications in kidney transplant recipients. Am J Transplant 2009; 9: 1811-1815
27. Pilmore HL, Skeans MA, Snyder JJ et al. Cardiovascular disease medications after renal transplantation: results from the patient outcomes in Renal Transplantation Study. Transplantation 2011; 91: 542-551
28. Thilly N, Bayat S, Alla F et al. Determinants and patterns of renin-angiotensin system inhibitors' prescription in the first year following kidney transplantation. Clin Transplant 2008; 22: 439-446